Keywords: شیمی درمانی دوم خط; Colorectal cancer; Second-line chemotherapy; Angiogenesis inhibitors; Systematic review; Pooled analysis;
مقالات ISI شیمی درمانی دوم خط (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: شیمی درمانی دوم خط; Low-risk; Gestational trophoblastic neoplasia; Methotrexate-resistance; Second-line chemotherapy; Carboplatin;
Keywords: شیمی درمانی دوم خط; Advanced gastric cancer; Second-line chemotherapy; Molecular targeted agents; Randomized controlled trials;
A phase II study of nab-paclitaxel in combination with ramucirumab in patients with previously treated advanced gastric cancer
Keywords: شیمی درمانی دوم خط; Advanced gastric cancer; Nab-paclitaxel; Paclitaxel; Ramucirumab; Overall response rate; Second-line chemotherapy;
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer
Keywords: شیمی درمانی دوم خط; Amrubicin; Salvage chemotherapy; Second-line chemotherapy; Small cell lung cancer; Weekly cisplatin plus etoposide plus irinotecan;
Gemcitabine as second-line chemotherapy after Folfirinox failure in advanced pancreatic adenocarcinoma: A retrospective study
Keywords: شیمی درمانی دوم خط; Advanced pancreatic cancer; Folfirinox; Gemcitabine; Second-line chemotherapy;
Biweekly irinotecan plus cisplatin versus irinotecan alone as second-line treatment for advanced gastric cancer: A randomised phase III trial (TCOG GI-0801/BIRIP trial)
Keywords: شیمی درمانی دوم خط; Gastric cancer; Second-line chemotherapy; Irinotecan; Cisplatin
Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status
Keywords: شیمی درمانی دوم خط; Erlotinib; Pemetrexed; Epidermal growth factor receptor (EGFR) mutation; Non-squamous non-small cell cancer; Second-line chemotherapy; Phase II;
Gemcitabine and Paclitaxel Combination as Second-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Phase II Study
Keywords: شیمی درمانی دوم خط; Gemcitabine; Paclitaxel; Second-line chemotherapy; Small-cell lung cancer
Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study
Keywords: شیمی درمانی دوم خط; Recurrent endometrial cancer; Platinum sensitivity; Second-line chemotherapy; Platinum-based chemotherapy
Efficacy and Safety of Oral Topotecan and Bevacizumab Combination as Second-Line Treatment for Relapsed Small-Cell Lung Cancer: An Open-Label Multicenter Single-Arm Phase II Study
Keywords: شیمی درمانی دوم خط; Anti–vascular endothelial growth factor receptor; Progression-free survival; Refractory small-cell lung cancer; Second-line chemotherapy; Topoisomerase inhibitor
A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study
Keywords: شیمی درمانی دوم خط; Biliary tract cancer; Second-line chemotherapy; Sunitinib;
A Prognostic Model to Identify Patients with Advanced Pancreas Adenocarcinoma Who Could Benefit from Second-line Chemotherapy
Keywords: شیمی درمانی دوم خط; Pancreatic adenocarcinoma; prognostic model; second-line chemotherapy;
ERCC1 and BRAC1 mRNA Expression Levels in the Primary Tumor Could Predict the Effectiveness of the Second-Line Cisplatin-Based Chemotherapy in Pretreated Patients with Metastatic Non-small Cell Lung Cancer
Keywords: شیمی درمانی دوم خط; BRCA1; ERCC1; NSCLC; Cisplatin; Second-line chemotherapy
A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe–Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019)
Keywords: شیمی درمانی دوم خط; Docetaxel; Non-small cell lung cancer; Oxaliplatin; Phase II; Second-line chemotherapy
Predictors and Impact of Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer in the United States: Real-World Considerations for Maintenance Therapy
Keywords: شیمی درمانی دوم خط; Non-small cell lung cancer; Metastatic; Second-line chemotherapy; Maintenance chemotherapy; Practice patterns; Radiation therapy; Insurance
Cost-Effectiveness of Second-Line Chemotherapy for Non-small Cell Lung Cancer: An Economic, Randomized, Prospective, Multicenter Phase III Trial Comparing Docetaxel and Pemetrexed: The GFPC 05-06 Study
Keywords: شیمی درمانی دوم خط; Non-small cell lung cancer; Second-line chemotherapy; Pemetrexed; Docetaxel; Cost-effectiveness; Cost-utility
Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies
Keywords: شیمی درمانی دوم خط; Cord blood-derived cytokine-induced killer (CB-CIK); Second-line chemotherapy; Advanced solid malignancies; Chemotherapy drug-resistance
Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis
Keywords: شیمی درمانی دوم خط; Second-line chemotherapy; Colorectal cancer; Irinotecan; FOLFIRI; Randomised phase II trial;
Re-challenge chemotherapy for relapsed non-small-cell lung cancer
Keywords: شیمی درمانی دوم خط; Re-challenge chemotherapy; Non-small-cell lung cancer; Second-line chemotherapy; Relapse; Platinum-based; Docetaxel
Phase II Trial of Amrubicin for Second-Line Treatment of Advanced Non-small Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG0401)
Keywords: شیمی درمانی دوم خط; Amrubicin; Non-small cell lung cancer (NSCLC); Platinum refractory; Second-line chemotherapy
A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0503
Keywords: شیمی درمانی دوم خط; Docetaxel; Non-small cell lung cancer; Second-line chemotherapy; S-1
Life after First-line Chemotherapy in Malignant Pleural Mesothelioma: a North-East England Experience
Keywords: شیمی درمانی دوم خط; Chemotherapy; mesothelioma; palliative; pemetrexed; radiotherapy; second-line chemotherapy;
Second-line therapy for advanced pancreatic cancer: A review of the literature and future directions
Keywords: شیمی درمانی دوم خط; Advanced pancreatic cancer; Second-line chemotherapy; Single-agent chemotherapy; Platinum-based combinations; Targeted agents
Influence of Previous Chemotherapy on the Efficacy of Subsequent Docetaxel Therapy in Advanced Non-small Cell Lung Cancer Patients
Keywords: شیمی درمانی دوم خط; Non-small cell lung cancer; Second-line chemotherapy; Docetaxel
Phase I/II Study of Docetaxel and S-1 in Patients with Previously Treated Non-small Cell Lung Cancer
Keywords: شیمی درمانی دوم خط; Phase I/II; Non-small cell lung cancer; Second-line chemotherapy; S-1; Docetaxel
Tegafur-Uracil Plus Gemcitabine Combination Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with Platinum
Keywords: شیمی درمانی دوم خط; Adenocarcinoma; Advanced nonsmall-cell lung cancer; Gemcitabine; Nonsmoking; Second-line chemotherapy; Tegafur-uracil
Is Irinotecan Plus Docetaxel Useful as Second-Line Therapy in Advanced Non-small Cell Lung Cancer?
Keywords: شیمی درمانی دوم خط; Docetaxel; Irinotecan; Second-line chemotherapy; Non-small cell lung cancer; Phase II; Randomized trial
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
Keywords: شیمی درمانی دوم خط; Nonsmall cell lung cancer; Gemcitabine; Paclitaxel; Second-line chemotherapy; Platinum; Gefitinib; Survival
Second-Line Treatment of Advanced Non-small Cell Lung Cancer
Keywords: شیمی درمانی دوم خط; Non-small cell lung cancer; Second-line chemotherapy; Docetaxel; Pemetrexed; Erlotinib
Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer
Keywords: شیمی درمانی دوم خط; Small cell lung cancer; Second-line chemotherapy; Liposomal doxorubicin; Caelyx; Relapsed lung cancer; Refractory lung cancer
Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer
Keywords: شیمی درمانی دوم خط; Etoposide; Second-line chemotherapy; Topotecan;
Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients
Keywords: شیمی درمانی دوم خط; Malignant mesothelioma; Raltitrexed; Oxaliplatin; Second-line chemotherapy;
Review of second-line chemotherapy for advanced gastric adenocarcinoma
Keywords: شیمی درمانی دوم خط; Gastric cancer; oesophageal cancer; second-line chemotherapy; salvage chemotherapy;